Lung injury induced by acute endotoxemia is associated with increased generation of inflammatory mediators such as nitric oxide and eicosanoids which have been implicated in the pathophysiological process. While production of these mediators by alveolar macrophages (AM) has been characterized, the response of Type II cells is unknown and was assessed in the present studies. Acute endotoxemia caused a rapid (within 1 h) and prolonged (up to 48 h) induction of nitric oxide synthase -2 (NOS-2) in Type II cells, but a delayed response in AM (12-24 h). In both cell types this was associated with increased nitric oxide production. Although Type II cells, and to a lesser extent AM, constitutively expressed cyclooxygenase-2 (COX-2), acute endotoxemia did not alter this activity. Endotoxin administration had no effect on mitogen activated protein kinase or protein kinase B-alpha (PKB-α) expression, however increases in phosphoinositide 3-kinase (PI3K) and phospho-PKB-α were observed in Type II cells.
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INTRODUCTION
Exposure of humans and animals to excessive amounts of bacterially-derived endotoxin is known to elicit an inflammatory reaction and can cause severe damage to various organs including the lung and liver (14) . Alveolar macrophages are known to play a central role in initiating and regulating endotoxin-induced inflammatory responses in the lung. This is accomplished through the release of a variety of mediators including cytokines, reactive oxygen intermediates, reactive nitrogen intermediates and eicosanoids by these cells (28, 49) . Type II alveolar epithelial cells are important in maintaining the functional and structural integrity of the alveolus. These cells not only synthesize and secrete surfactant, but also act as progenitors for injured Type I epithelial cells (1, 19) . A number of studies have suggested that Type II cells also have the capacity to participate in inflammatory processes. Thus in response to cytokines, Type II cells, like alveolar macrophages, release tumor necrosis factor-α, interleukin-8, monocyte chemotactic protein, macrophage inflammatory protein-2, nitric oxide, hydrogen peroxide, and prostaglandins (13, 23, 31, 39, 40, 43, 56, 57) . The functional and biochemical responses of Type II cells during acute endotoxemia are largely unknown and an analysis of their activity when compared to alveolar macrophages represents the focus of the present studies. We found that administration of endotoxin to rats resulted in induction of nitric oxide synthase-2 (NOS-2) protein and increased nitric oxide production in both cell types. Nuclear factor-kappa B (NF-κB) and interferon regulatory factor-1 (IRF-1), two key transcription factors known to activate genes that generate inflammatory mediators were also induced in Type II cells and alveolar macrophages by endotoxin, however the kinetics of their responses were different. The results of our studies provide support for the concept that Type II cells, like alveolar macrophages, participate in pulmonary inflammatory responses to irritants although their actions may be distinct.
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MATERIALS AND METHODS
Animals and Treatment
Female specific pathogen-free Sprague-Dawley rats (200-225 g, 6-8 weeks) were purchased from Taconic (Germantown, NY). Animals were housed in microisolator cages and maintained on sterile food and pyrogen-free water ad libitum. Acute endotoxemia was induced by intravenous injection of rats with 5 mg/kg Escherichia coli lipopolysaccharide (LPS, serotype 0128:B12, Sigma Chemical Co., St. Louis, MO).
Cell Isolation
Rats were euthanized by intraperitoneal injection of Nembutal (125 mg/kg). The lungs were perfused with 50 ml of warm (37 0 C) Ca +2 /Mg +2 -free Hank's balanced salt solution (HBSS, pH 7.4) containing 2.5 M HEPES, 0.5 M EGTA and 4.4 M NaHCO 3 at a rate of 22 ml/min followed by perfusion with 50 ml HBSS without EGTA. Lungs were then lavaged 5-6 times with HBSS to collect alveolar macrophages. Cells were washed 3-4 times with HBSS containing 2% FCS. Cell viability was 98% as determined by trypan blue dye exclusion, and cell purity greater than 97% as determined morphologically after Giemsa staining.
Type II cells were isolated from lavaged lungs as previously described (17, 40) .
After washing twice with 10 ml of buffer (140 mM NaCl, 5 mM KCl, 2.5 mM Na 2 HPO 4 , 10 mM HEPES, 1.3 mM MgSO 4 .7H 2 O, pH 7.4, 2 mM CaCl 2 ), 30 ml of elastase (4.2 U/ml, Worthington Biochemicals, NJ) was infused into the lungs using a 60 cc syringe.
The tissue was then incubated at 37 0 C for 20 min, the trachea and major bronchi removed, the lungs minced in the presence of 4 ml DNAse (1 µg/ml), and then digested for 5 min at 37 0 C with 10 ml of elastase. The reaction was stopped by the addition of 
Preparation of Cytoplasmic and Nuclear Extracts
Cytoplasmic extracts for western blotting and nuclear extracts for the electrophoretic mobility shift assays (EMSA) were prepared as previously described (10 
Western Blot Analysis
Cytoplasmic proteins were fractionated on sodium dodecyl sulfate polyacrylamide gels 
Electrophoretic Mobility Shift Assays (EMSA)
EMSA were performed as described previously (10) 
RESULTS
Effects of Acute Endotoxemia on NOS-2 Expression and Nitric Oxide Production
In initial studies, we analyzed the effects of endotoxin treatment of rats on expression of NOS-2, the enzyme mediating the generation of nitric oxide in Type II cells and alveolar macrophages (31, 33, 38, 40) . NOS-2 protein was not detectable in freshly isolated
Type II cells or alveolar macrophages from control animals ( Figure 1 ). Endotoxin administration resulted in a time dependent induction of NOS-2 in both cell types.
However, the kinetics of their responses were distinct. Thus, while in Type II cells NOS-2 protein was expressed as early as 1 h after endotoxin administration and persisted for at least 48 h, in alveolar macrophages this response was delayed.
Moreover in these cells NOS-2 protein declined to control levels after 24 h ( Figure 1 ).
We also analyzed the effects of acute endotoxemia on nitric oxide production by 
Effects of Acute Endotoxemia on COX-2 Expression
In our next series of studies we determined if Type II cells and alveolar macrophages were activated following endotoxin administration to express increased amounts of COX-2, the enzyme mediating inducible prostaglandin biosynthesis (36, 47) . Freshly isolated Type II cells from control animals were found to constitutively express COX-2 protein ( Figure 1 ). Two protein bands were detected in the blots, the lower band most likely reflecting a COX-2 breakdown product. Although similar results were observed in alveolar macrophages, significantly greater quantities of COX-2 protein were identified in Type II cells. In contrast to its effects on NOS-2, induction of acute endotoxemia had no major effects on COX-2 expression in either cell type ( Figure 1 ).
Biochemical Activation of Type II Cells and Alveolar Macrophages During Acute Endotoxemia
In further studies we determined if acute endotoxemia was associated with biochemical activation of the cells. Initially we analyzed expression of p38 and p44/42 MAPK, which are thought to be involved in the regulation of both NOS-2 and COX-2 (8, 11, 20) . 
Effects of Acute Endotoxemia on NF-κB and IRF-1 Nuclear Binding Activity
The transcription factors NF-κB and IRF-1 are known to regulate the expression of numerous inflammatory genes including NOS-2 and COX-2 (6, 9, 20) . We next 
Effects of Inhibiting NF-κB on NOS-2 Expression and Nitric Oxide Production
To analyze the potential role of NF-κB in NOS-2 expression and nitric oxide production, we used PDTC, which has been reported to block NF-κB nuclear binding activity (7, 51) .
PDTC was found to cause a dose related inhibition of NOS-2 protein expression in the cells with maximum effects at 2.5 µM (Figure 3) . Type II cells and alveolar macrophages from endotoxin treated rats were less sensitive to the inhibitory effects of PDTC on NOS-2 protein expression than were cells from control animals. We also found that PDTC treatment caused a dose dependent inhibition of nitric oxide production by both Type II cells and alveolar macrophages, reaching a maximum with 2.5 µM (Figure 7 ). At this concentration PDTC had no effect on cell viability (not shown). Alveolar macrophages from endotoxin treated rats were less sensitive to the inhibitory effects of PDTC on nitric oxide production than were cells from control animals. To exclude the possibility that PDTC was acting as a nitrite scavenger (44), we quantified nitrite levels in a standard solution containing increasing concentrations of sodium nitrite (5-35 µM) in the presence and absence of 5 µM PDTC. We found that PDTC had no effect on nitrite levels in the solution (not shown). Moreover, EMSA
showed that PDTC was effective in blocking NF-κB nuclear binding activity in Type II cells and alveolar macrophages (not shown). (29, 40, 46) . The present studies demonstrate that a number of functional and biochemical activities are upregulated or induced in Type II cells following endotoxin administration to rats. In fact these cells appear to be more responsive to endotoxin than alveolar macrophages.
DISCUSSION
These findings are similar to our studies on interstitial macrophages (53, 54) , and suggest that close association with the endothelium increases the sensitivity of cells to intravenously administered endotoxin.
Nitric oxide is a highly reactive molecule produced in Type II cells and alveolar macrophages by the NADPH dependent enzyme NOS-2 (31, 33, 38, 40) . We found that acute endotoxemia caused a rapid and time dependent induction of NOS-2 in Type II cells, suggesting that these cells are highly responsive to in vivo endotoxin. This is supported by our findings that Type II cells from endotoxemic animals are sensitized to produce more nitric oxide and express greater amounts of NOS-2 after treatment with IFN-γ plus LPS, when compared to cells from control animals. Our data are consistent with previous findings of increased NOS-2 in Type II cells following ozone inhalation (40) and support the idea that these cells are an important part of the inflammatory response to pulmonary irritants. The relatively delayed production of nitric oxide in vitro by Type II cells following endotoxin administration, when compared to alveolar macrophages, suggests that they may need to be activated or primed for mediator production. As described previously (53) , alveolar macrophages were also found to produce more nitric oxide in response to inflammatory mediators after endotoxin administration to rats. However, the response of these cells was more rapid when compared to Type II cells (12 h versus 24 h). This is consistent with a primary role of alveolar macrophages in the pulmonary inflammatory response (21, 26, 58) .
Prostaglandins are highly reactive lipid mediators released during inflammatory responses from arachidonic acid via the enzyme COX-2 (36, 47) . We found that COX-2 was constitutively expressed in Type II cells, as well as alveolar macrophages from control rats. This is in accord with previous studies examining rat and mouse lung macrophages (18, 50) . These findings suggest that COX-2 may be important in maintaining homeostatic pulmonary activity. In this regard, COX-2-dependent pathways have been implicated in the regulation of lung vascular tone, alveolar epithelial permeability, surfactant homeostasis and lung development (4, 16, 25, 30, 41, 48) .
Endotoxin administration to the animals had no significant effect on expression of COX-2 in Type II cells or alveolar macrophages. This indicates that COX-2 expression in these cells does not limit prostaglandin production in the lung during endotoxin-induced inflammation.
MAPK signaling pathways are known to play a central role in the regulation of a number of inflammatory responses including NOS-2 and COX-2 expression (8, 11, 20) .
Our studies revealed that both p38 and p44/42 MAPK were constitutively expressed in Type II cells from control animals, which may explain constitutive expression of COX-2 in these cells. Endotoxin administration had no effect on expression of either total MAPK or phospho-MAPK. These findings are consistent with the lack of effects of endotoxin on COX-2. It should be noted however that it is not known if the MAPK are functionally active in Type II cells. Additional studies are required to determine the precise role of MAPK in these cells. Constitutive p38 MAPK and phospho-p38 MAPK were also detected in alveolar macrophages and, as observed in Type II cells, these proteins were unaffected by endotoxin administration. These results, together with the observation that alveolar macrophages did not express phospho-p44/42 MAPK in response to endotoxin, suggest that activation of these proteins may not be required for NOS-2 expression in these lung cells. This idea is supported by recent studies in mouse macrophage and epithelial cell lines demonstrating that activation of p44/42
MAPK is not essential for LPS-induced NOS-2 expression (27).
Constitutive expression of PI3K, PKB-α and phospho-PKB-α was also observed in Type II cells from control animals. It has been suggested that PI3K is involved in the regulation of MAPK, as well as COX-2 (34). Our findings that expression of PI3K and phospho-PKB-α increased after endotoxin administration to the animals provides additional support for the concept that Type II cells are activated during acute endotoxemia. The observation that PI3K and phospho-PKB-α expression are induced in Type II cells during acute endotoxemia is novel. At the present time, the functions of these proteins in Type II cell activation are unknown. Although they may be involved in constitutive COX-2 expression, PI3K and PKB-α may also contribute to Type II cell survival, proliferation, protein synthesis and/or glucose transport and this remains to be determined (3, 37, 45) . Alveolar macrophages from control animals also constitutively expressed PI3K and PKB-α, but not phospho-PKB-α. Whereas endotoxin treatment of the animals induced PI3K, it had no effect on either PKB-α or phospho-PKB-α expression. This suggests distinct functions for PKB-α in Type II cells and alveolar macrophages during endotoxin-induced lung injury.
The promoter regions of both the NOS-2 and COX-2 genes contain consensus sequences for the transcription factors NF-κB and IRF-1, which presumably regulate the activity of these genes (6, 9, 20) . Cells were isolated from control animals (C) or 1-48 h after endotoxin administration.
Cytoplasmic extracts were prepared immediately after isolation and equal amounts analyzed by western blotting. One representative gel from three separate experiments is shown. 
